FDA Inspection 1192248 — Philip M. Ginsburg, M.D.
The FDA completed an inspection of Philip M. Ginsburg, M.D. on Dec 1, 2022 in Hamden, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 1, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hamden, CT (United States)
Additional Details
Clinical Investigator (CI)